L. Bruno

发表

TP53 mutations and S‐phase fraction but not DNA‐ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma

A. Russo, S. Corsale, V. Agnese, 2006, Journal of cellular physiology.

TP 53 Mutations and S-Phase Fraction but not DNA-Ploidy Are Independent Prognostic Indicators in Laryngeal Squamous Cell Carcinoma

A. Russo, S. Corsale, V. Agnese, 2005 .

A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer

A. Russo, S. Corsale, V. Agnese, 2006, Breast Cancer Research and Treatment.

TP53 and p16INK4A, but not H‐KI‐Ras, are involved in tumorigenesis and progression of pleomorphic adenomas

A. Russo, S. Corsale, V. Agnese, 2006, Journal of cellular physiology.

The Clinical Significance of Unknown Sequence Variants in BRCA Genes

A. Russo, L. Bruno, V. Caló, 2010, Cancers.

BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses

A. Giordano, A. Russo, S. Corsale, 2007, Breast Cancer Research and Treatment.

Role of S128R polymorphism of E‐selectin in colon metastasis formation

A. Russo, L. Bruno, G. Seidita, 2007, International journal of cancer.

Hereditary ovarian cancer.

A. Russo, L. Bruno, V. Bazan, 2009, Critical reviews in oncology/hematology.

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

A. Russo, V. Agnese, S. Cascio, 2008, Breast Cancer Research and Treatment.

4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).

A. Russo, V. Agnese, S. Cascio, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

V. Adamo, S. Corsale, V. Agnese, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.